Cancer Vaccine

Wednesday, January 11, 2017 - 12:01am

We know that cancers related to HPV (human papillomavirus) are common, on the rise and, for more than a decade, preventable. Roswell Park teams specializing in cancer prevention and ways to eliminate health disparities have spent a lot of time trying to understand a dynamic we’ve observed — why aren’t more families taking advantage of HPV vaccination, a powerful opportunity to prevent some very serious and possibly fatal cancers before they develop?

Tuesday, November 1, 2016 - 2:29pm
Roswell Park is opening a clinical trial to study the CIMAvax-EGF® vaccine, a cancer treatment that was developed in Cuba. It will be used to treat lung cancer, the most common cause of cancer death worldwide. This vaccine trial is innovative in three significant ways.
Monday, March 28, 2016 - 4:42pm

Roswell Park Cancer Institute made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CIMAvax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CIMAvax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”

Tuesday, September 1, 2015 - 2:20pm

Amid a historic normalizing of relations between the United States and Cuba, a potentially game-changing step was recently taken in the field of lung cancer research.

Tuesday, June 16, 2015 - 3:52pm
Last month, Roswell Park made headlines around the world with the announcement that we expect to be the first U.S. institution to offer a lung cancer treatment vaccine developed by the Center for Molecular Immunology in Cuba.
Friday, February 13, 2015 - 1:15pm

The human papillomavirus, or HPV, continues to be a preventable cause of many cancer cases across the globe. The most common type of cancer associated with HPV is cervical cancer, but it can also cause anal, vaginal, vulvar, penile and some kinds of throat cancer.

Monday, June 30, 2014 - 9:42am

Immunotherapy—using the power of the immune system to fight cancer—is a hot topic in scientific research, so much so that it has earned its own month. June is recognized as Immunotherapy Awareness Month.

Monday, January 6, 2014 - 7:49am

The most common malignant primary brain tumor is called glioblastoma multiforme. These tumors are often aggressive and infiltrate surrounding brain tissue.

Tuesday, June 4, 2013 - 11:59am

A Phase I clinical trial, funded by the American Cancer Society and launched through Roswell Park Cancer Institute's Center for Imm